Changes in isoenzyme patterns of a cloned culture of nonpathogenic Entamoeba histolytica during axenization.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMC 260244)

Published in Infect Immun on December 01, 1986

Authors

D Mirelman, R Bracha, A Wexler, A Chayen

Articles citing this

Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol (1995) 2.31

Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A (1989) 2.23

DNA probes specific for Entamoeba histolytica possessing pathogenic and nonpathogenic zymodemes. Infect Immun (1989) 2.22

Differentiation of pathogenic from nonpathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro. J Clin Microbiol (1991) 2.00

Thiol proteinase expression and pathogenicity of Entamoeba histolytica. J Clin Microbiol (1989) 1.60

Remarkable genetic polymorphism among Entamoeba histolytica isolates from a limited geographic area. J Clin Microbiol (2002) 1.53

Differences in genomic DNA sequences between pathogenic and nonpathogenic isolates of Entamoeba histolytica identified by polymerase chain reaction. J Clin Microbiol (1991) 1.40

Differentiation of clinical isolates of Entamoeba histolytica by using specific DNA probes. J Clin Microbiol (1990) 1.25

Cloning of a virulence factor of Entamoeba histolytica. Pathogenic strains possess a unique cysteine proteinase gene. J Clin Invest (1993) 1.18

Ameba-bacterium relationship in amebiasis. Microbiol Rev (1987) 1.18

Identification of a pathogenic isolate-specific 30,000-Mr antigen of Entamoeba histolytica by using a monoclonal antibody. Infect Immun (1990) 1.15

Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates. Infect Immun (1992) 0.99

Amebiasis. Clin Microbiol Rev (1992) 0.94

Specific labeling of cysteine proteinases in pathogenic and nonpathogenic Entamoeba histolytica. Infect Immun (1990) 0.94

Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica. Clin Diagn Lab Immunol (1997) 0.89

Molecular cloning of a 30-kilodalton lysine-rich surface antigen from a nonpathogenic Entamoeba histolytica strain and its expression in a pathogenic strain. Infect Immun (1995) 0.86

Modulation of a surface antigen of Entamoeba histolytica in response to bacteria. Infect Immun (1992) 0.86

Characterization of a monoclonal antibody that selectively recognizes a subset of Entamoeba histolytica isolates. Infect Immun (1990) 0.85

Repetitive DNA elements characteristic of pathogenic Entamoeba histolytica strains can also be detected after polymerase chain reaction in a cloned nonpathogenic strain. Infect Immun (1990) 0.83

Electrophoretic karyotype and chromosome assignments for a pathogenic and a nonpathogenic strain of Entamoeba histolytica. Infect Immun (1993) 0.78

Appearance of sialoglycoproteins in encysting cells of Entamoeba histolytica. Infect Immun (1988) 0.77

Articles cited by this

Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol (1977) 17.41

A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg (1978) 13.65

Techniques of axenic cultivation of Entamoeba histolytica Schaudinn, 1903 and E. histolytica-like amebae. J Parasitol (1968) 4.28

The laboratory diagnosis of human parasitic amoebae. Trans R Soc Trop Med Hyg (1968) 3.22

Biochemical homogeneity of Entamoeba histolytica isolates, especially those from liver abscess. Lancet (1982) 1.77

A comparative study of Entamoeba histolytica (NIH :200, HK9, etc.), "E. histolytica-like" and other morphologically identical amoebae using isoenzyme electrophoresis. Trans R Soc Trop Med Hyg (1980) 1.73

Frequency distribution of Entamoeba histolytica zymodemes in a rural South African population. Lancet (1985) 1.63

Virulence of Entamoeba histolytica trophozoites. Effects of bacteria, microaerobic conditions, and metronidazole. J Exp Med (1984) 1.59

Entamoeba histolytica: effect of growth conditions and bacterial associates on isoenzyme patterns and virulence. Exp Parasitol (1986) 1.57

Genetic and epigenetic control of several isozymic systems in Tetrahymena. Ann N Y Acad Sci (1968) 1.55

A new liquid medium for xenic cultivation of Entamoeba histolytica and other lumen-dwelling protozoa. J Parasitol (1982) 1.53

Electrophoretic isoenzyme patterns of Entamoeba histolytica and Entamoeba coli. Trans R Soc Trop Med Hyg (1978) 1.43

THE PRODUCTION OF BACTERIA-FREE AMOEBIC ABSCESSES IN THE LIVER OF CATS AND OBSERVATIONS ON THE AMOEBAE IN VARIOUS MEDIA WITH AND WITHOUT BACTERIA. Science (1930) 1.40

Zymodemes expressing possible genetic exchange in Entamoeba histolytica. Trans R Soc Trop Med Hyg (1985) 1.14

Resistance to lysis by human serum of pathogenic Entamoeba histolytica. Trans R Soc Trop Med Hyg (1983) 1.11

A review of isoenzyme characterization of Entamoeba histolytica with particular reference to pathogenic and non-pathogenic stocks isolated in Mexico. Arch Invest Med (Mex) (1982) 0.91

Entamoeba histolytica: virulence enhancement of isoenzyme-stable parasites. Exp Parasitol (1984) 0.88

Clonal growth of Entamoeba in agar: some applications of this technique to the study of their cell biology. Arch Invest Med (Mex) (1978) 0.83

A mouse model for Entamoeba histolytica infection. Lab Anim (1985) 0.83

Articles by these authors

Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature (1977) 10.17

Mannose residues on phagocytes as receptors for the attachment of Escherichia coli and Salmonella typhi. Biochem Biophys Res Commun (1977) 4.24

Novel type of murein transglycosylase in Escherichia coli. J Bacteriol (1975) 4.16

Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis (1979) 3.82

Isolation of a mannose-specific lectin from Escherichia coli and its role in the adherence of the bacteria to epithelial cells. Biochem Biophys Res Commun (1978) 3.62

Properties of a novel pleiotropic bacteriophage-resistant mutant of Staphylococcus aureus H. J Bacteriol (1969) 3.42

Peptidoglycan biosynthesis in a thermosensitive division mutant of Escherichia coli. Biochemistry (1976) 2.68

Inhibition of fungal growth by wheat germ agglutinin. Nature (1975) 2.35

Antimicrobial properties of allicin from garlic. Microbes Infect (1999) 2.30

Regulation of murein biosynthesis and septum formation in filamentous cells of Escherichia coli PAT 84. J Bacteriol (1977) 2.25

DNA probes specific for Entamoeba histolytica possessing pathogenic and nonpathogenic zymodemes. Infect Immun (1989) 2.22

Neuropsychological impairment from acute low-level exposure to carbon monoxide. Arch Neurol (1998) 2.22

Studies on the elongation of bacterial cell wall peptidoglycan and its inhibition by penicillin. Ann N Y Acad Sci (1974) 2.10

Screening of bacterial isolates for mannose-specific lectin activity by agglutination of yeasts. J Clin Microbiol (1980) 2.03

Mannose-binding activity of Escherichia coli: a determinant of attachment and ingestion of the bacteria by macrophages. Infect Immun (1980) 1.98

Entamoeba histolytica ribosomal RNA genes are carried on palindromic circular DNA molecules. Mol Biochem Parasitol (1989) 1.92

Role of the penicillin-sensitive transpeptidation reaction in attachment of newly synthesized peptidoglycan to cell walls of Micrococcus luteus. Proc Natl Acad Sci U S A (1972) 1.89

Adherence of Shigella flexneri to guinea pig intestinal cells is mediated by a mucosal adhesion. Infect Immun (1982) 1.86

Quantitative determination of N-acetylglucosamine residues at the non-reducing ends of peptidoglycan chains by enzymic attachment of [14C]-D-galactose. Eur J Biochem (1976) 1.83

Insensitivity of peptidoglycan biosynthetic reactions to beta-lactam antibiotics in a clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 1.78

Ribitol teichoic acid synthesis in bacteriophage-resistant mutants of Staphylococcus aureus H. J Biol Chem (1970) 1.76

Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg (1981) 1.73

Penicillin-induced secretion of soluble, uncross-linked peptidoglycan by Micrococcus luteus cells. Biochemistry (1974) 1.68

Pathogenic and nonpathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin. Infect Immun (1990) 1.67

Virulence of Entamoeba histolytica trophozoites. Effects of bacteria, microaerobic conditions, and metronidazole. J Exp Med (1984) 1.59

Biosynthesis of peptidoglycan by a cell wall preparation of Staphylococcus aureus and its inhibition by penicillin. Biochem Biophys Res Commun (1972) 1.57

Entamoeba histolytica: effect of growth conditions and bacterial associates on isoenzyme patterns and virulence. Exp Parasitol (1986) 1.57

Lectin activity in Entamoeba histolytica trophozoites. Infect Immun (1980) 1.57

Studies on growth inhibition by lectins of Penicillia and Aspergilli. Arch Microbiol (1978) 1.54

Preparation and properties of a cytotoxic monoclonal rat anti-mouse Thy-1 antibody. J Immunol Methods (1982) 1.43

Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis. Mol Microbiol (2000) 1.43

Constant peptidoglycan density in the sacculus of Escherichia coli B/r growing at different rates. FEBS Lett (1979) 1.42

Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect Immun (1987) 1.41

Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica-induced formation of liver abscess in hamsters. Infect Immun (1999) 1.40

Antisense inhibition of expression of cysteine proteinases does not affect Entamoeba histolytica cytopathic or haemolytic activity but inhibits phagocytosis. Mol Microbiol (1998) 1.35

Murein biosynthesis during a synchromous cell cycle of Escherichia coli B. J Bacteriol (1978) 1.32

Antisense inhibition of expression of the light subunit (35 kDa) of the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence. Mol Microbiol (1999) 1.27

Adherence and ingestion of Escherichia coli serotype 055 by trophozoites of Entamoeba histolytica. Infect Immun (1983) 1.27

Soluble nascent peptidoglycan in growing Escherichia coli cells. J Biol Chem (1980) 1.26

Differentiation of clinical isolates of Entamoeba histolytica by using specific DNA probes. J Clin Microbiol (1990) 1.25

Entamoeba histolytica: cloning and characterization of actin cDNA. Mol Biochem Parasitol (1987) 1.25

Interaction of wheat-germ agglutinin with bacterial cells and cell-wall polymers. Eur J Biochem (1975) 1.24

Attachment and ingestion of bacteria by trophozoites of Entamoeba histolytica. Infect Immun (1982) 1.20

Nature and origins of phosphorus compounds in isolated cell walls of Staphylococcus aureus. J Bacteriol (1971) 1.19

Ameba-bacterium relationship in amebiasis. Microbiol Rev (1987) 1.18

The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta (2000) 1.17

Regulation of the terminal steps in peptidoglycan biosynthesis in ether-treated cells of Escherichia coli. FEBS Lett (1980) 1.17

The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta (1998) 1.17

Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction. J AAPOS (2001) 1.15

The major surface antigens of Entamoeba histolytica trophozoites are GPI-anchored proteophosphoglycans. J Mol Biol (2000) 1.14

Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids. Parasitology (1997) 1.12

Adhesion of Entamoeba histolytica trophozoites to monolayers of human cells. J Infect Dis (1981) 1.12

In vitro system for the synthesis of teichoic acid linked to peptidoglycan. J Bacteriol (1976) 1.11

An intermediate in telchoic acid biosynthesis. Biochem Biophys Res Commun (1976) 1.11

Mutants of staphylococci with altered cell walls. Ann N Y Acad Sci (1974) 1.10

Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence. Mol Microbiol (1999) 1.10

Isolation and characterization of two disaccharide-peptides from lysozyme digests of Micrococcus lysodeikticus cell walls. Biochem Biophys Res Commun (1966) 1.06

Biosynthesis of peptidoglycan in Pseudomonas aeruginosa. 1. The incorporation of peptidoglycan into the cell wall. Eur J Biochem (1979) 1.05

Nucleotide sequence analysis of an Entamoeba histolytica ferredoxin gene. Mol Biochem Parasitol (1988) 1.04

Chitin synthesis inhibitors prevent cyst formation by Entamoeba trophozoites. Biochem Biophys Res Commun (1982) 1.03

Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. Exp Parasitol (1988) 1.03

B cell subpopulations in the mouse: analysis with monoclonal antibodies NIM-R2 and NIM-R3. Eur J Immunol (1982) 1.03

Down regulation of Entamoeba histolytica virulence by monoxenic cultivation with Escherichia coli O55 is related to a decrease in expression of the light (35-kilodalton) subunit of the Gal/GalNAc lectin. Infect Immun (1999) 1.03

Interaction between trophozoites of Entamoeba histolytica and the human intestinal cell line HT-29 in the presence or absence of leukocytes. Parasitol Res (1993) 1.03

Encystation of Entamoeba invadens IP-1 is induced by lowering the osmotic pressure and depletion of nutrients from the medium. J Protozool (1986) 1.02

Mode of action of Myxococcus xanthus antibiotic TA. Antimicrob Agents Chemother (1981) 1.01

Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer (2000) 1.01

The location of the D-alanyl ester in the ribitol teichoic acid of Staphylococcus aureus. Biochem Biophys Res Commun (1970) 1.01

Mycobacterium fortuitum keratitis. Am J Ophthalmol (1974) 0.99

Analysis by enzyme-linked immunosorbent assay and PCR of human liver abscess aspirates from patients in China for Entamoeba histolytica. J Clin Microbiol (1999) 0.99

A spectrophotometric assay for allicin and alliinase (Alliin lyase) activity: reaction of 2-nitro-5-thiobenzoate with thiosulfinates. Anal Biochem (1998) 0.99

Isolation, purification, and partial characterization of an enterotoxin from extracts of Entamoeba histolytica trophozoites. Infect Immun (1985) 0.98

Isolation and characterization of the disaccharide N-acetyl-glucosaminyl-beta(1 bound to 4)-N-acetylmuramic acid and two tripeptide derivatives of this disaccharide from lysozyme digests of Bacillus licheniformis ATCC 9945 cell walls. J Biol Chem (1968) 0.98

Inhibition of expression of the lysine-rich 30 kDa surface antigen of Entamoeba dispar by the transcription of its antisense RNA. Mol Biochem Parasitol (1997) 0.98

Inhibition of growth of Entamoeba histolytica by allicin, the active principle of garlic extract (Allium sativum). J Infect Dis (1987) 0.98

Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic. Coron Artery Dis (1995) 0.97

Antibodies against a synthetic peptidoglycan-precursor pentapeptide cross-react with at least two distinct populations of uncross-linked soluble peptidoglycan secreted by Micrococcus luteus cells. Eur J Biochem (1978) 0.97

Interactions between Entamoeba histolytica, bacteria and intestinal cells. Ciba Found Symp (1983) 0.96

S-Allylmercaptoglutathione: the reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim Biophys Acta (2000) 0.95

Defect in biosynthesis of the linkage unit between peptidoglycan and teichoic acid in a bacteriophage-resistant mutant of Staphylococcus aureus. J Bacteriol (1978) 0.95

Biosynthesis of peptidoglycan in Pseudomonas aeruginosa: comparison of the inhibitory effects of cefotaxime, its anti isomer, and the syn S-oxide compound. Antimicrob Agents Chemother (1980) 0.95